You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Coronary Thrombosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Thrombosis Trial (Primary Percutaneous coronary angiography)

Not yet recruiting
  • Coronary Thrombosis
  • Primary Percutaneous coronary angiography
  • (no location specified)
Dec 3, 2022

NON-INVASIVE CORONARY THROMBUS IMAGING TO DEFINE THE CAUSE OF

Not yet recruiting
  • Myocardial Infarction
  • Thrombosis
  • Hybrid 18F-GP1 positron emission tomography and coronary computed tomography coronary angiography
  • Edinburgh, United Kingdom
    Royal Infirmary of Edinburgh
Oct 27, 2023

Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Beijing (Aspirin + Clopidogrel +

Not yet recruiting
  • Coronary Artery Disease
  • +2 more
  • Aspirin + Clopidogrel + Rivaroxaban
  • Aspirin + Clopidogrel
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences, Fuwai Hospital
Dec 5, 2022

Coronary Disease, Coronary Artery Disease, Coronary Restenosis Trial in Lucerne (Impact of current PCI techniques/ devices in

Recruiting
  • Coronary Disease
  • +9 more
  • Impact of current PCI techniques/ devices in complex coronary artery lesions
  • Lucerne, Switzerland
    Lucerne Heart Centre
Oct 4, 2023

Hemorrhagic and Ischemic Events in Post-angioplasty in

Recruiting
  • Atrial Fibrillation
  • +3 more
  • Blood panel
  • Nîmes, France
    CHU de Nîmes
Jan 2, 2023

Laboratory Indices to Left Ventricular Thrombus Formation in

Not yet recruiting
  • Left Ventricular Thrombus
  • Primary percutaneous coronary intervention or thrombolytic therapy
  • (no location specified)
Nov 29, 2023

Patients Undergoing Coronary Angiography and Percutaneous

Not yet recruiting
  • Chronic Coronary Insufficiency
  • Smoking
    • (no location specified)
    Apr 13, 2022

    Coronary Artery Disease, Healthy Participants Trial in Edinburgh (Ticagrelor, BMS-986141, Aspirin)

    Recruiting
    • Coronary Artery Disease
    • Healthy Participants
    • Edinburgh, United Kingdom
      Local Institution - 0001
    May 3, 2022

    Saphenous Vein Graft Disease Trial in Boca Raton, Ottawa (Aspirin, Ticagrelor)

    Completed
    • Saphenous Vein Graft Disease
    • Boca Raton, Florida
    • +1 more
    May 16, 2022

    Genetic Variant Scores and P2Y12 Inhibitor Effects

    Recruiting
    • Stent Thrombosis
    • +3 more
      • Seongnam-si, Gyonggi-do, Korea, Republic of
        SNUBH
      Jul 18, 2022

      Coronary Disease, Coronary Artery Disease, Coronary Restenosis Trial in Lucerne (Sirolimus Eluting Balloon)

      Recruiting
      • Coronary Disease
      • +9 more
      • Sirolimus Eluting Balloon
      • Lucerne, Switzerland
        Luzerner Heart Centre
      Mar 31, 2022

      Embolism and Thrombosis of the Radial Artery, Coronary Heart Disease Trial in Ottawa (Glidesheath Slender, standard 6- French

      Completed
      • Embolism and Thrombosis of the Radial Artery
      • Coronary Heart Disease
      • Glidesheath Slender
      • standard 6- French radial sheath
      • Ottawa, Ontario, Canada
        University of Ottawa Heart Institute
      Jan 27, 2022

      PTRG-DES Consortium

      Completed
      • Coronary Artery Disease
      • +3 more
      • Clopidogrel Tablets
      • Changwon, Gyeongsangnam-do, Korea, Republic of
        Gyeongsang National University Changwon Hospital
      Mar 15, 2022

      Definite Stent Thrombosis in Comatose Out of Hospital Cardiac

      Completed
      • Out of Hospital Cardiac Arrest
      • +3 more
        • Ljubljana, Slovenia
          University Medical Centre Ljubljana
        Sep 29, 2021

        Platelet Function in Patients Undergoing Open Heart Surgery

        Recruiting
        • Coronary Artery Bypass Grafting
        • +3 more
        • Open Heart Surgery
        • Baltimore, Maryland
          Sinai Center for Thrombosis Research
        Jun 28, 2022

        Thrombosis, Myocardial Infarction Trial (Rivaroxaban, Ticagrelor)

        Not yet recruiting
        • Thrombosis
        • Myocardial Infarction
        • (no location specified)
        Nov 2, 2021

        Pan-Cardio-Genetics Clot Assessment in Acute Coronary Syndromes

        Withdrawn
        • STEMI - ST Elevation Myocardial Infarction
        • +2 more
        • thrombus aspiration
        • Thessaloníki, Greece
          AHEPA University Hospital
        Feb 16, 2022

        Potential Adverse Outcomes in Routine Clinical Practice

        Completed
        • Venous Thrombosis
        • +3 more
        • Rivaroxaban (Xarelto, Bay59-7939)
        • Standard of care
        • Multiple Locations, Germany
          (unnamed)
        Oct 21, 2021

        Coronary Artery Disease, Coronary Thrombosis Trial in La Jolla (Medtronic Endeavor Stent, Reduced duration (6 months) DAPT)

        Completed
        • Coronary Artery Disease
        • Coronary Thrombosis
        • Medtronic Endeavor Stent
        • Reduced duration (6 months) DAPT
        • La Jolla, California
          Scripps Clinic
        Oct 19, 2020

        Potential Adverse Outcomes in Routine Clinical Pratice

        Completed
        • Venous Thrombosis
        • +3 more
        • Rivaroxoban (Xarelto, Bay59-7939)
        • Standard of care
        • Multiple Locations, Netherlands
          (unnamed)
        Sep 22, 2021

        Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

        Completed
        • Acute Coronary Syndrome
        • +3 more
        • Rivaroxaban (Xarelto, BAY59-7939)
        • Standard of care drugs
        • Multiple Locations, Sweden
          Many Locations
        Sep 22, 2021

        Potential Adverse Outcomes in Routine Clinical Pratice (UK)

        Completed
        • Venous Thrombosis
        • +3 more
        • Rivaroxaban (Xarelto, Bay59-7939)
        • +2 more
        • Multiple Locations, United Kingdom
          (unnamed)
        Sep 22, 2021

        Acute Coronary Syndrome, Myocardial Infarction, Atrial Fibrillation Trial (First month DAPT, First month standard therapy)

        Not yet recruiting
        • Acute Coronary Syndrome
        • +10 more
        • First month DAPT
        • First month standard therapy
        • (no location specified)
        Apr 16, 2021

        Cardiovascular Diseases, Acute Coronary Syndrome Trial in Newark, Baltimore, Danville (clopidogrel, prasugrel)

        Terminated
        Has Results
        • Cardiovascular Diseases
        • Acute Coronary Syndrome
        • Newark, Delaware
        • +4 more
        Mar 7, 2022

        Acute Coronary Syndrome, Left Ventricular Thrombus Trial in Karachi (Rivaroxaban, Warfarin)

        Recruiting
        • Acute Coronary Syndrome
        • Left Ventricular Thrombus
        • Karachi, Sindh, Pakistan
          National Institute of Cardiovascular Diseases
        Jul 10, 2021